|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/28 | |
| C07K 16/28 | |||
| A61K 9/19 | |||
| A61K 47/18 | |||
| A61K 39/395 | |||
| A61K 47/26 |
| (11) | Number of the document | 2844286 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13729089.6 |
| Date of filing the European patent application | 2013-05-02 | |
| (97) | Date of publication of the European application | 2015-03-11 |
| (45) | Date of publication and mention of the grant of the patent | 2020-02-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2013/053490 |
| Date | 2013-05-02 |
| (87) | Number | WO 2013/164789 |
| Date | 2013-11-07 |
| (30) | Number | Date | Country code |
| 201261642644 P | 2012-05-04 | US |
| (72) |
MUELLER,Claudia, CH
WILLMANN, Matthias, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | LYOPHILISED AND AQUEOUS ANTI-CD40 ANTIBODY FORMULATIONS |
| LYOPHILISED AND AQUEOUS ANTI-CD40 ANTIBODY FORMULATIONS |